A new device dubbed Verisante Aura that just launched in Canada could help dermatologists save lives by determining whether or not a suspicious mole is melanoma in a matter of seconds. The best part: no pain, and no biopsy required.

Until now, a diagnosis of melanoma, the deadliest form of skin cancer, has required a dermatologist examining moles to decide whether or not to biopsy. For patients whose melanoma isn't caught early, the life expectancy is less than a year, putting abundant pressure on doctors to get the diagnosis right, and right away.